This correlation suggests a complex interplay between these genes and pathways, influencing tumor progression and therapeutic responses in HNSCC. Head and neck cancers often have genetic mutations that activate oncogenes like PIK3CA or inactivate the PTEN tumor suppressor gene. The gene discussed is PTEN; the disease is head and neck cancer.